Company profile: CU Chemie Uetikon
1.1 - Company Overview
Company description
- Provider of chemical and pharmaceutical production services via a state-of-the-art multi purpose plant in Europe, featuring a high standard cGMP API-production facility (MPA P3) on its manufacturing site in Lahr, Germany. Core competence includes the custom synthesis of Fine Chemical Intermediates.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CU Chemie Uetikon
Aldevron
HQ: United States
Website
- Description: Provider of contract manufacturing and scientific services in cell and genetic engineering, specializing in plasmid DNA, protein/enzyme production, and antibody generation. Offers plasmid DNA manufacturing (research to clinical), nanoplasmid design/retrofit, mRNA manufacturing and encapsulation, CRISPR nucleases, RNP complexes, and in vitro transcription and capping enzymes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aldevron company profile →
PHMR
HQ: United Kingdom
Website
- Description: Provider of strategic consulting services to biopharmaceutical, diagnostics, MedTech, and life science companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PHMR company profile →
Adare Pharma Solutions
HQ: United States
Website
- Description: Provider of global technology-driven CDMO services spanning research, business and product development, formulation development (taste masking, customized release, patient-centered dosage forms), analytical services, clinical trial materials manufacturing and packaging (GMP and Non-GMP), commercial manufacturing, packaging, and logistical support, with delivery technologies including Diffucaps®, Microcaps®, and Optimμm®.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adare Pharma Solutions company profile →
Aliada Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapies for central nervous system diseases, leveraging the MODEL platform to deliver large molecules across the blood-brain barrier via small modular protein domains. Offerings include ALIA-1758, a bispecific antibody targeting pyroglutamate amyloid beta and TfR for potentially clearing amyloid beta plaques in Alzheimer’s disease, and partner programs to develop brain-accessible therapeutics for lysosomal storage disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aliada Therapeutics company profile →
Meridian Clinical Research
HQ: Germany
Website
- Description: Provider of a multi-specialty network that facilitates clinical trials for vaccines, drugs, medical devices & diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meridian Clinical Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CU Chemie Uetikon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CU Chemie Uetikon
2.2 - Growth funds investing in similar companies to CU Chemie Uetikon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CU Chemie Uetikon
4.2 - Public trading comparable groups for CU Chemie Uetikon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →